AU2001256350A1 - Regulation of human lysostaphin-like protease - Google Patents
Regulation of human lysostaphin-like proteaseInfo
- Publication number
- AU2001256350A1 AU2001256350A1 AU2001256350A AU5635001A AU2001256350A1 AU 2001256350 A1 AU2001256350 A1 AU 2001256350A1 AU 2001256350 A AU2001256350 A AU 2001256350A AU 5635001 A AU5635001 A AU 5635001A AU 2001256350 A1 AU2001256350 A1 AU 2001256350A1
- Authority
- AU
- Australia
- Prior art keywords
- lysostaphin
- protease
- regulation
- human
- human lysostaphin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6489—Metalloendopeptidases (3.4.24)
- C12N9/6491—Matrix metalloproteases [MMP's], e.g. interstitial collagenase (3.4.24.7); Stromelysins (3.4.24.17; 3.2.1.22); Matrilysin (3.4.24.23)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Biotechnology (AREA)
- Pain & Pain Management (AREA)
- Microbiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20390800P | 2000-05-12 | 2000-05-12 | |
| US60203908 | 2000-05-12 | ||
| PCT/EP2001/005347 WO2001085959A2 (en) | 2000-05-12 | 2001-05-10 | Regulation of human lysostaphin-like protease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001256350A1 true AU2001256350A1 (en) | 2001-11-20 |
Family
ID=22755795
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001256350A Abandoned AU2001256350A1 (en) | 2000-05-12 | 2001-05-10 | Regulation of human lysostaphin-like protease |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2001256350A1 (en) |
| WO (1) | WO2001085959A2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050118159A1 (en) * | 2001-12-21 | 2005-06-02 | Stinson Jeffrey R. | Truncated lysostaphin molecule with enhanced staphylolytic activity |
| ES2353690T3 (en) | 2002-10-03 | 2011-03-04 | Neuropharmacology Services, Llc | OXYCHOCINE FOR USE IN THE TREATMENT OF AUTISM AND ASPERGER'S DISORDER. |
-
2001
- 2001-05-10 WO PCT/EP2001/005347 patent/WO2001085959A2/en not_active Ceased
- 2001-05-10 AU AU2001256350A patent/AU2001256350A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001085959A2 (en) | 2001-11-15 |
| WO2001085959A3 (en) | 2002-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002224553A1 (en) | Human proteases | |
| AU2001278488A1 (en) | Regulation of human matriptase-like serine protease | |
| AU2001281967A1 (en) | Regulation of human desc1-like serine protease | |
| AU8573401A (en) | Regulation of human epithin-like serine protease | |
| AU2002234568A1 (en) | Regulation of human serine palmitoyltransferase | |
| AU2001281950A1 (en) | Regulation of human thimet oligopeptidase-like enzyme | |
| AU2001269095A1 (en) | Regulation of human caspase-1-like protease | |
| AU2001266089A1 (en) | Regulation of human prostasin-like serine protease | |
| AU2001274080A1 (en) | Regulation of human transketolase-like enzyme | |
| AU2001256350A1 (en) | Regulation of human lysostaphin-like protease | |
| AU2001293718A1 (en) | Regulation of human membrane-type serine protease | |
| AU2002219046A1 (en) | Regulation of human ceruloplasmin-like protein | |
| AU2002215956A1 (en) | Regulation of human pgc-1-like protein | |
| AU2002231620A1 (en) | Regulation of human patched-like protein | |
| AU2001268967A1 (en) | Regulation of human epithin-like serine protease | |
| AU2001285782A1 (en) | Regulation of human phosphodiesterase-like enzyme | |
| AU2002215942A1 (en) | Regulation of human carboxylesterase-like enzyme | |
| AU2001281969A1 (en) | Regulation of human carboxylesterase-like enzyme | |
| AU2002210525A1 (en) | Regulation of human phospholipase-like enzyme | |
| AU2002237225A1 (en) | Regulation of human patched-like protein | |
| AU2001279752A1 (en) | Regulation of human masp-like serine protease | |
| AU2002213949A1 (en) | Regulation of human serine protease | |
| AU2001258330A1 (en) | New uses of imidazolylmethyl-pyridines | |
| AU2002212246A1 (en) | Regulation of human serine palmitoyltransferase-like enzyme | |
| AU2001267548A1 (en) | Regulation of human napsin-like aspartyl protease |